IBSA Farmaceutici Italia srl
IBSA Farmaceutici is a member of the IBSA Group. Established in 1992, the company has a head office in Lodi, two manufacturing sites near Milan, 3 R&D labs, a branch office in Roma, a workforce of over 500 resources and an annual turnover of over 250 million euros. These are just some of the figures that makes us a scientific economic and industrial leader in the Italian pharmaceutical sector.
Our production lines are characterised by state-of-the-art technology and environmental sustainability and our Research & Development activities employ latest-generation technologies to optimise the bioavailability, efficacy and safety of existing active substances in order to develop simpler, more evolved treatment systems as part of our commitment to provide healthcare professionals with efficacious and reliable novel treatment solutions able to improve patients’ quality of life.
The original results of a number of Italian studies, of which many developed in partnership with our universities, are protected by international patent. To this day IBSA holds 82 registered patent families and many others in development.
We contribute to the success of Italian industry by placing on the market products developed by Italian researchers and manufactured by technical staff and workers in Italy before being sold in 90 countries worldwide.
Our product portfolio covers 10 different therapeutic areas and includes different therapeutic categories, such as prescription drugs, OTC medicines, medical devices and food supplements.
The company’s on-going investments in human resources, innovation and productive capacity allow it to maintain a healthy new product pipeline.
As a member of the IBSA Group, our work is based on the fundamental pillars People, Innovation, Quality and Responsibility and all company activities are performed in compliance with the principles set forth in the Group’s Ethical Code and Anti-bribery Guidelines, in the firm conviction that an attention to the lawfulness, principles and values they enshrine are essential conditions of company life.